Atherosclerosis, which currently contributes to 31% of deaths globally, is of critical
cardiovascular concern. Current diagnostic tools and biomarkers are limited, emphasizing …

Background: Cardiovascular and cerebrovascular disease (CCVD) is the leading cause of
morbidity and mortality worldwide, imposing a significant economic burden on individuals …

Silica nanoparticles (SiNPs) could induce adverse pulmonary effects, but the mechanism
was not clear enough. Metabolomics is a sensitive and high-throughput approach that could …

The prevalence of cardiovascular diseases continues to be a challenge for global health,
necessitating innovative solutions. The potential of high-density lipoprotein (HDL) mimetic …

Globally, atherosclerotic cardiovascular disease (ASCVD) accounts for more disability and
deaths than any other human condition. 1 We now recognize that atherosclerosis is not only …

The paradigm of regenerative medicine is undergoing a transformative shift with the
emergence of nanoengineered silica-based biomaterials. Their unique confluence of …

(1) Background: Nanomedicine, incorporating various nanoparticles and nanomaterials,
offers significant potential in medical practice. Its clinical adoption, however, faces …

Аннотация Актуальность. Введение некоторых лекарств вызывает нежелательные
явления, связанные с системным воздействием действующего вещества на организм …

This study was designed to investigate the toxic response of Sprague Dawley (SD) rats
following oral administration of different doses of silica nanoparticles (SiNPs) for 94 …